Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Inhaled Alpha-1 Antitrypsin in Preventing Bronchiolitis Obliterable Syndrome in Lung Transplant Recipients

NCT01394835 is registered in ClinicalTrials.gov with Rabin Medical Center as lead sponsor.

NCT NCT01394835
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01394835 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Inhaled Alpha-1 Antitrypsin in Preventing Bronchiolitis Obliterable Syndrome in Lung Transplant Recipients
Lead sponsor
Rabin Medical Center
Phase
Phase 2
Overall status
Unknown status
Start date
September 30, 2011
Completion date
September 30, 2013
Enrollment
40 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

bronchiolitis obliterable syndrome, lung transplantation